OracleBio’s Chief Scientific Officer, Lorcan Sherry, recently joined Aleksandra Zuraw on the Digital Pathology Place podcast.
During the podcast, Aleks and Lorcan have a conversation about the history of OracleBio and the company’s journey to GCP Image Analysis. Listen to the episode to hear Aleks and Lorcan discuss:
- Lorcan’s background and the origins of OracleBio
- OracleBio’s use of image analysis software platforms
- Processes for assuring image analysis data is of a high quality
- Pathologist input throughout the image analysis workflow
- How the company innovates
- and more!
Reasons to Work With OracleBio:
Data you can trust – We have thorough quality control procedures in place throughout our workflow to ensure the data we provide is of a high-quality standard
Latest technologies – We continually invest time and money into the latest software and techniques so you don’t need to
More from OracleBio:
In July 2021, the creation of OracleBio’s dedicated Research & Development group marked an important milestone in our growth strategy. In this article, we go behind the scenes and take a retrospective look at what we have achieved over the past year, and give you...
In this article, we will briefly discuss different methods to detect and segment nuclei and in particular, give examples of how artificial intelligence (AI) Deep Learning (DL) methods are increasingly being applied within our organisation to streamline our image...
Following on from our previous article on Tertiary Lymphoid Structures (TLS), in which OracleBio clinical pathologist Gabriele Kohnen discussed the potential role of Tertiary Lymphoid Structures in normal and diseased tissues, this article describes some recent work...
Find out more about our Software Capabilities
OracleBio's Quantitative Digital Pathology Services
Stay up to date with OracleBio
Sign up to our mailing list to stay informed about news, webinars, events and more